Skip to main content
Clinical Trials/ISRCTN79554459
ISRCTN79554459
Completed
Not Applicable

A study of potentially curative local therapy alone, or preceded by chemotherapy, in the treatment of Stage Ib-IVa cervical carcinoma

Medical Research Council (MRC) (UK)0 sites313 target enrollmentFebruary 28, 2001

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cervical cancer
Sponsor
Medical Research Council (MRC) (UK)
Enrollment
313
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 28, 2001
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Medical Research Council (MRC) (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Histologically proven invasive cancer of the cervix Stage Ib through to IVa
  • 2\. Patients must be fit enough to receive adjuvant chemotherapy, and the chosen definitive treatment
  • 3\. World Health Organisation (WHO) performance status zero to one or creatinine clearance of at least 60 ml/min
  • 4\. The informed consent of the patient

Exclusion Criteria

  • 1\. Previous chemotherapy
  • 2\. Renal, hepatic or bone marrow dysfunction which in the opinion of the investigator is sufficient to prejudice therapy (including local treatment and chemotherapy
  • 3\. Previous malignancy other than basal cell carcinoma
  • 4\. Medical or psychological conditions precluding treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials